Left Ventricular Diastolic Dysfunction as Predictor of Unfavorable Prognosis After ESUS
Agata Bielecka-Dabrowa1,2, Paulina Gasiorek2, Andrzej Wittczak2
1Heart Failure Unit, Department of Cardiology and Congenital Diseases of Adults, Polish Mother's Memorial Hospital Research Institute (PMMHRI), Lodz, Poland.
Insights
Diastolic dysfunction predicts poor outcomes in embolic strokes of undetermined origin (ESUS) patients under 65. Early diastolic mitral annular velocity (E/E') is a key predictor of recurrent stroke and composite endpoints.
Area of Science:
- Cardiology
- Neurology
- Medical Diagnostics
Background:
- Embolic strokes of undetermined etiology (ESUS) represent a significant proportion of ischemic strokes.
- Predicting prognosis in younger ESUS patients (<65 years) requires identification of specific risk factors.
- Echocardiographic and hemodynamic parameters may offer insights into stroke risk.
Purpose of the Study:
- To identify echocardiographic, hemodynamic, and biochemical predictors of unfavorable prognosis in patients under 65 with ESUS.
- To assess the association of these predictors with cardiovascular hospitalizations, recurrent stroke, and composite endpoints.
Main Methods:
- A cohort of 64 ESUS patients and 36 controls underwent echocardiography and non-invasive hemodynamic assessment.
- Biomarkers were measured, and patients were followed for 12 months.
- Multivariate analysis was used to identify independent predictors of adverse outcomes.
Main Results:
- The ratio of early diastolic transmitral flow to early diastolic mitral annular motion (E/E") was an independent predictor of recurrent stroke (OR 0.75, p=0.01).
- E/E" was also associated with a composite endpoint of death, hospitalization, and recurrent stroke (OR 1.90, p=0.01).
- Mean early diastolic mitral annular velocity (E') was linked to cardiovascular hospitalizations (OR 0.75, p=0.01).
Conclusions:
- Indices of diastolic dysfunction, particularly E/E", are significantly associated with unfavorable prognosis in younger ESUS patients.
- Outpatient cardiac monitoring, especially in the first two months post-hospitalization, is crucial for detecting atrial fibrillation (AF).
- These findings highlight the importance of diastolic function assessment in managing ESUS.
Objective:
Identification of echocardiographic, hemodynamic and biochemical predictors of unfavorable prognosis after embolic strokes of undetermined etiology (ESUS) in patients at age <65.
Patients And Methods:
Out of 520 ischemic stroke patients we selected 64 diagnosed with ESUS and additional 36 without stroke but with similar risk profile. All patients underwent echocardiography, non-invasive assessment of hemodynamic parameters using SphygmoCor tonometer and measurements of selected biomarkers. Follow-up time was 12 months.
Results:
Nine percent of patients died, and recurrent ischemic stroke occurred in 9% of patients only in the ESUS group. Atrial fibrillation (AF) occurred in 10% of patients and the ESUS group had a significantly poorer outcome of AF in the first 2 months after hospitalization. The outcome of re-hospitalization was 28% in the ESUS group and 17% in the control group. In the multivariate analysis mean early diastolic (E') mitral annular velocity (OR 0.75, 95% CI: 0.6-0.94; p=0.01) was significantly associated with cardiovascular hospitalizations. The only independent predictor of recurrent stroke was the ratio of peak velocity of early diastolic transmitral flow to peak velocity of early diastolic mitral annular motion (E/E') (OR 0.75, 95% CI: 0.6-0.94; p=0.01). E/E' was independently associated with composite endpoint (death, hospitalization and recurrent stroke) (OR 1.90, 95% CI 1.1-3.2, p=0.01).
Conclusion:
The indices of diastolic dysfunction are significantly associated with unfavorable prognosis after ESUS. There is a robust role for outpatient cardiac monitoring especially during the first 2 months after ESUS to detect potential AF.
Related Concept Videos
Mitral Stenosis I: Introduction
Heart Failure II: Pathophysiology
Mitral Regurgitation I: Introduction
Pathophysiology of Heart Failure
Mitral Stenosis II: Clinical features and Diagnostic Tests
Cardiomyopathy II: Dilated Cardiomyopathy


